JPH0364510B2 - - Google Patents

Info

Publication number
JPH0364510B2
JPH0364510B2 JP61028013A JP2801386A JPH0364510B2 JP H0364510 B2 JPH0364510 B2 JP H0364510B2 JP 61028013 A JP61028013 A JP 61028013A JP 2801386 A JP2801386 A JP 2801386A JP H0364510 B2 JPH0364510 B2 JP H0364510B2
Authority
JP
Japan
Prior art keywords
group
represented
formula
above formula
epoxycholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61028013A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62187485A (ja
Inventor
Junichi Oshida
Kenji Ishimaru
Hideki Tsuruta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP61028013A priority Critical patent/JPS62187485A/ja
Publication of JPS62187485A publication Critical patent/JPS62187485A/ja
Publication of JPH0364510B2 publication Critical patent/JPH0364510B2/ja
Granted legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Steroid Compounds (AREA)
JP61028013A 1986-02-13 1986-02-13 24,25−エポキシコレステロ−ル類の製造法 Granted JPS62187485A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61028013A JPS62187485A (ja) 1986-02-13 1986-02-13 24,25−エポキシコレステロ−ル類の製造法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61028013A JPS62187485A (ja) 1986-02-13 1986-02-13 24,25−エポキシコレステロ−ル類の製造法

Publications (2)

Publication Number Publication Date
JPS62187485A JPS62187485A (ja) 1987-08-15
JPH0364510B2 true JPH0364510B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-10-07

Family

ID=12236888

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61028013A Granted JPS62187485A (ja) 1986-02-13 1986-02-13 24,25−エポキシコレステロ−ル類の製造法

Country Status (1)

Country Link
JP (1) JPS62187485A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20230747T1 (hr) 2011-09-08 2024-01-05 Sage Therapeutics, Inc. Neuroaktivni steroidi, pripravci i njihova uporaba
ES2886506T3 (es) 2013-03-13 2021-12-20 Sage Therapeutics Inc Esteroides neuroactivos
US10259840B2 (en) 2014-06-18 2019-04-16 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
CA2991311A1 (en) * 2015-07-06 2017-01-12 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
PH12020551586A1 (en) 2015-07-06 2023-07-31 Sage Therapeutics Inc Oxysterols and methods of use thereof
DK3828194T3 (da) 2015-07-06 2025-06-30 Sage Therapeutics Inc Oxysteroler og fremgangsmåder til anvendelse deraf
CN109195604B (zh) 2016-04-01 2023-11-14 萨奇治疗股份有限公司 氧甾醇及其使用方法
WO2017193046A1 (en) 2016-05-06 2017-11-09 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
HUE055263T2 (hu) 2016-07-07 2021-11-29 Sage Therapeutics Inc 11-Szubsztituált 24-hidroxiszterolok NMDA-hoz kapcsolódó állapotok kezelésére
PT3519422T (pt) 2016-09-30 2022-12-05 Sage Therapeutics Inc Oxisteróis substituídos em c7 e métodos como moduladores nmda
TWI836485B (zh) 2016-10-18 2024-03-21 美商賽吉醫療公司 氧固醇(oxysterol)及其使用方法
EP3529257B1 (en) 2016-10-18 2023-05-10 Sage Therapeutics, Inc. Oxysterols and methods of use thereof

Also Published As

Publication number Publication date
JPS62187485A (ja) 1987-08-15

Similar Documents

Publication Publication Date Title
JPH0364510B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2003506425A (ja) ナプロキセンのニトロキシアルキルエステルの製造法
EP0038614A2 (en) Esters of 5- and 6-oxo-prostaglandins
JPS5840960B2 (ja) ヒドロキシコレステロ−ル立体異性体間の相互変換法
JPH0432063B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0402982B1 (en) Adduct-aldehyde and its use for the preparation of a vitamin-D compound
EP0045524B1 (en) 22-arylsulfonyl-24,25-dihydroxycholestanes and process for preparing the same
GB2036744A (en) Eburnane derivatives
EP0432029B1 (fr) Procédé de préparation de synergistines
KR100241263B1 (ko) N-알킬옥시카르보닐-베타-알킬술포닐발린 화합물의 제조방법
EP2146954B1 (fr) Procede de synthese de l'acide (z)-3-[2-butoxy-3'-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl]-2-methoxy-acrylique
JP3256259B2 (ja) スルホン誘導体の製造方法
JPH0353299B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH09124629A (ja) カルバミン酸テトラヒドロフリルエステル誘導体の製造方法
US3992411A (en) 2α-Formyl-3β-[(methoxalyl)oxy]-5-oxo-1β-cyclopentaneheptanoic acid and process
JPS6287599A (ja) エリスロマイシン類のオキシム誘導体の製造法
JPH0364507B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP3283959B2 (ja) D−ビオチン中間体およびその製造法
JPS6126555B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2002234897A (ja) ビタミンdおよびステロイド誘導体の合成用中間体およびその製造方法
JPH0616667A (ja) ピラゾロ[1,5−aピリジン誘導体の新規製造方法
FR2518998A1 (fr) Nouveaux derives heterocycliques d'acide acetique et procede pour leur preparation
JPH024234B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2019131510A (ja) ルビプロストンの製造方法
JPS6220997B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees